Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SGMT - Sagimet Biosciences Inc - Ordinary Shares - Class A


IEX Last Trade
3.08
0   0%

Share volume: 143,374
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$3.08
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
4.76%
1 Month
-13.24%
3 Months
-42.96%
6 Months
-51.80%
1 Year
-74.23%
2 Year
-80.69%
Key data
Stock price
$3.08
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.13 - $20.71
52 WEEK CHANGE
-$0.74
MARKET CAP 
94.479 M
YIELD 
N/A
SHARES OUTSTANDING 
30.675 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
BETA 
2.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$120,888
AVERAGE 30 VOLUME 
$213,824
Company detail
CEO: George Kemble
Region: US
Website: https://sagimet.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news